JAKS NURSERY LIMITED
Executive Summary
JAKS NURSERY LIMITED shows encouraging financial improvement with enhanced net assets, strong liquidity, and growing working capital. However, its young operational history and reliance on director loans suggest a cautious approach. Credit can be conditionally approved with emphasis on monitoring debtor collections, profitability, and related-party loan management.
View Full Analysis Report →Company Documents
| Date | Description |
|---|---|
| 29/07/2529 July 2025 New | Total exemption full accounts made up to 2024-10-31 |
| 25/11/2425 November 2024 | Change of share class name or designation |
| 25/11/2425 November 2024 | Change of share class name or designation |
| 25/11/2425 November 2024 | Change of share class name or designation |
| 19/11/2419 November 2024 | Confirmation statement made on 2024-11-07 with updates |
| 19/11/2419 November 2024 | Cessation of Joanne Louise Watson as a person with significant control on 2024-07-29 |
| 19/11/2419 November 2024 | Notification of a person with significant control statement |
| 31/10/2431 October 2024 | Annual accounts for year ending 31 Oct 2024 |
| 15/11/2315 November 2023 | Confirmation statement made on 2023-11-07 with no updates |
| 31/10/2331 October 2023 | Annual accounts for year ending 31 Oct 2023 |
| 18/07/2318 July 2023 | Total exemption full accounts made up to 2022-10-31 |
| 29/12/2229 December 2022 | Previous accounting period shortened from 2022-11-30 to 2022-10-31 |
| 31/10/2231 October 2022 | Annual accounts for year ending 31 Oct 2022 |
| 08/11/218 November 2021 | Incorporation |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company